TCR2 Therapeutics Inc. (TCRR): Price and Financial Metrics
TCRR Price/Volume Stats
| Current price | $1.48 | 52-week high | $3.88 |
| Prev. close | $1.57 | 52-week low | $0.82 |
| Day low | $1.48 | Volume | 3,913,300 |
| Day high | $1.63 | Avg. volume | 494,777 |
| 50-day MA | $1.69 | Dividend yield | N/A |
| 200-day MA | $1.64 | Market Cap | 58.11M |
TCRR Stock Price Chart Interactive Chart >
TCR2 Therapeutics Inc. (TCRR) Company Bio
TCR2 Therapeutics, Inc. is an immunotherapy company, which develops biological drugs and engineering T-cells for cancer therapy. The company offers cancer therapy, T-cell biology, Immunology and Molecular biology. It also engages in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded in May 2015 and is headquartered in Cambridge, MA.
TCRR Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -68.97% |
| 5-year | -91.72% |
| YTD | N/A |
| 2023 | 0.00% |
| 2022 | -78.57% |
| 2021 | -84.93% |
| 2020 | 116.60% |
| 2019 | N/A |
Loading social stream, please wait...